Lipid Nanoparticles Market worth $395.0 million by 2031
The report "Lipid Nanoparticles Market by Product (Ionizable lipids, Phospholipids, Neutral Lipids), Type (SLNs, NLCs), Molecule (siRNA, mRNA), Application, Service Type (Formulation Development, Manufacturing), End User, Region - Global Forecast to 2031", is projected to grow from USD 298.8 million in 2026 and to reach USD 395.0 million by 2031, at a Compound Annual Growth Rate (CAGR) of 5.7% during the forecast period.
Browse 408 market data Tables and 57 Figures spread through 328 Pages and in-depth TOC on "Lipid Nanoparticles Market by Product (Ionizable lipids, Phospholipids, Neutral Lipids), Type (SLNs, NLCs), Molecule (siRNA, mRNA), Application, Service Type (Formulation Development, Manufacturing), End User, Region - Global Forecast to 2031"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/lipid-nanoparticles-market-70136984.html
The global lipid nanoparticle market is growing, driven by the expanding development and commercialization of mRNA vaccines and therapeutics, siRNA-based medicines, and other nucleic acid therapeutics. Rising demand for high-purity pharmaceutical-grade lipids, scalable LNP formulation technologies, and specialized development and manufacturing capabilities is further supporting market expansion.
The ionizable lipids segment accounted for the largest share of the global LNP raw materials market, by product, in 2025.
By product, the LNP raw materials market is segmented into ionizable lipids, PEGylated lipids, neutral lipids, phospholipids, kits & reagents, and other formulation materials. The ionizable lipids segment accounted for the largest share of the LNP raw materials market in 2025, driven by their critical roles in nucleic acid encapsulation, endosomal escape, and intracellular delivery. Ionizable lipids are central to the performance of LNP formulations for mRNA and siRNA delivery, and their structure strongly influences particle stability, delivery efficiency, biodistribution, and tolerability. Continued investment in next-generation ionizable lipid chemistries to improve potency, biodegradability, and tissue-selective delivery further supports the segment’s leading position.
The mRNA segment is likely to be the fastest-growing molecule type segment in the LNP market.
The global LNP market is segmented by molecule type into siRNA, mRNA, and other molecules. During the forecast period, the mRNA segment is projected to be the fastest-growing, driven by an expanding pipeline of mRNA vaccines and therapeutics across infectious diseases, oncology, protein replacement, and other therapeutic applications. LNPs play a critical role in protecting mRNA from degradation, facilitating cellular uptake, and enabling efficient intracellular delivery. The commercial validation of mRNA-LNP technology, continued investment in next-generation mRNA platforms, and growing clinical development of mRNA-based therapeutics are expected to accelerate demand for LNP raw materials and associated development and manufacturing capabilities worldwide.
North America accounted for the largest regional share in the global LNP raw materials & services market in 2025.
The LNP raw materials & services market is segmented into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. In 2025, North America held the largest share of the global market, driven by a strong concentration of pharmaceutical and biotechnology companies developing mRNA, siRNA, gene-editing, and other nucleic acid therapeutics. The region benefits from advanced biopharmaceutical R&D infrastructure, substantial investment in RNA-based drug development, and specialized lipid suppliers, LNP technology developers, and contract development and manufacturing organizations. Ongoing clinical development and commercialization of LNP-enabled therapeutics, along with investments in domestic biomanufacturing capacity, further support the region’s leading market position.
Key players in the LNP raw materials and services market include Avanti Polar Lipids (Croda International Plc.) (US), Merck KGaA (Germany), Evonik Industries AG (Germany), Nippon Fine Chemical Co., Ltd. (Japan), NOF Corporation (Japan), FUJIFILM Pharmaceuticals, Inc. (FUJIFILM Holdings Corporation) (US), Precision NanoSystems (Canada), Recipharm AB (Sweden), Emergent BioSolutions, Inc. (US), EUROAPI (France), Cayman Chemical (US), CordenPharma (Switzerland), Gattefossé (France), Acuitas Therapeutics (Canada), and IOI Oleo GmbH (Germany).
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: [email protected]
Visit Our Website: https://www.marketsandmarkets.com
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Lipid Nanoparticles Market
- What will your New Revenue Sources be
- Who will be your Top Customer; what will make them switch
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
